Trial Profile
A Phase II Study of Pancreatic Enzyme Replacement (Zenpep) on Completion Rates of Adjuvant Chemotherapy Among Subjects With Resected Pancreatic Ductal Adenocarcinoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs Pancrelipase (Primary)
- Indications Exocrine pancreatic insufficiency
- Focus Therapeutic Use
- 11 Feb 2020 Status changed from recruiting to discontinued.
- 06 Mar 2019 Status changed from not yet recruiting to recruiting.
- 02 Apr 2018 Planned initiation date changed from 30 Mar 2018 to 16 Apr 2018.